First Application of Haselmeier's Injection Pen Launched


Haselmeier recently announced that the first application of its Axis-D pen platform has been launched. Commissioned by its client Merck Serono, a division of Merck KGaA, Germany, the new injection device has been designed to allow self-injection by patients of a ready-to-use biopharmaceutical solution for injection.

“With the Axis pen platform, it is easy to tailor the injection device to various needs. Following our client’s specifications, we have developed a device that enables users to adjust the volume of the injection and reuse the pen several times until the cartridge is empty. For security reasons, we added a function to the pen to immediately confirm that a complete dose was delivered, or to indicate the missing amount if an incomplete dose is injected,” said Volker Wirth, Director Business Development & Marketing at Haselmeier. “We are proud of this successful collaboration with Merck Serono, and we look forward to continuing our business relationship in the future.”

The Axis pen platform is available as a reusable or disposable multi-use pen, which features adjustable dosing. The pen design is based on an innovative technology featuring a sliding dose window that allows easy reading of the dose and provides reduced risk of incorrect dosing. Available in metal or plastic, the Axis pen is compatible with 3-ml cartridges, all fill volumes, and can be customized to meet any patient needs.

Haselmeier is a leading designer and manufacturer of pen and auto-injection systems. The company’s devices feature unique function, design, and technology and are marketed by leading pharmaceutical and biotechnology companies around the world.